Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec®... (issued patents and pending worldwide pat...)

Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe

Date:7/28/2011

issued patents and pending worldwide patent applications, orBec® benefits from orphan drug designations in the US and in Europe for the treatment of GI GVHD, as well as an orphan drug designation in the US for the prevention of acute GVHD and the treatment of chronic GI GVHD. Orphan drug designations provide for 7 and 10 years of market exclusivity upon approval in the US and Europe, respectively. orBec® has also received Fast Track designation from the FDA for the treatment of GI GVHD.

About GVHD

GVHD is a painful, debilitating and sometimes fatal disease. It is a common disorder among immunocompromised cancer patients after receiving allogeneic stem cell or bone marrow transplants. Unlike organ transplants where the patient's body may reject the organ, in GVHD it is the donor cells that begin to attack the patient's body – most frequently the gut, liver and skin. Patients with mild-to-moderate GI GVHD typically develop symptoms of anorexia, nausea, vomiting and diarrhea. If left untreated, GI GVHD can progress to ulcerations in the lining of the GI tract, and in its most severe form, can be fatal.

Systemic immunosuppressive agents such as prednisone, which are the current standard treatments for GVHD, are associated with high mortality rates due to infection and debility. Further, these drugs have not been approved for treating GVHD in the US or European Union, but rather are used off-label for this indication.

About the Sigma-Tau Group

The Sigma-Tau Group is a leading international pharmaceutical group with wholly Italian-owned capital that invests in the research, development and marketing of innovative and effective treatments to improve patient well-being and quality of life. Sigma-Tau was founded in Italy in 1957 and achieved global revenues of euro 673 million in 2010. Sigma-Tau Group has headquarters in Pomezia (Rome, Italy), and subsidiaries
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. Soligenix Announces Appointment of Jerome Zeldis, MD, PhD and Keith Brownlie, CPA to its Board of Directors
2. Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
3. Soligenix to Present at 13th Annual BIO CEO & Investor Conference
4. Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
5. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
6. Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury
7. Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
8. Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT
9. Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant
10. Soligenix to Present at the OneMedForum Conference on Wednesday, June 30 at 2PM EDT
11. Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration

Post Your Comments:

(Date:5/23/2013)... , May 23, 2013 Israel Brain ... 2013 , Israel,s 1 st ... 14 th -15 th in Tel Aviv ... innovative city in the world by the Wall Street ... BrainTech Israel 2013 will showcase the latest breakthroughs in ...

(Date:5/23/2013)... 2013 Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ... the development and commercialization of novel bile acid therapeutics ... cirrhosis, today announced that Mark Pruzanski ... at the Deutsche Bank Securities 38th Annual Health Care ... May 29, 2013 at 4:10 p.m. ET. ...

(Date:5/23/2013)... May 23, 2013 MedVantx, Inc., the company that ... channel announced today the Company has completed a major ... in pharmaceutical products and the upgrade of its systems ... facilities in its specialty home delivery pharmacy in ... leading pharmaceutical manufacturers, physicians, health systems and payors novel ...

Breaking Medicine Technology:Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2 Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3 MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2 MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3

[0] Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference [0] Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference [0] MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy

... 2012 The " Home Healthcare ... Forecasts to 2016 " analyzes and studies the ... and Rest of the World. Browse ... " Home Healthcare Market (Equipment, Service & ...

... Calif., April 4, 2012 Life Technologies Corporation (NASDAQ: ... with several partners to develop applications for its Ion Personal ... HLAs are found on the surfaces of ... the combination of HLA sub-types found in their tissues. Tissue ...

Cached Medicine Technology:MarketsandMarkets: Global Home Healthcare Market Worth $296 Billion by 2016 2 MarketsandMarkets: Global Home Healthcare Market Worth $296 Billion by 2016 3 Life Technologies to Accelerate Adoption of Next-Generation Sequencing in HLA Through Key Partnerships 2 Life Technologies to Accelerate Adoption of Next-Generation Sequencing in HLA Through Key Partnerships 3 Life Technologies to Accelerate Adoption of Next-Generation Sequencing in HLA Through Key Partnerships 4

MarketsandMarkets: Global Home Healthcare Market Worth $296 Billion by 2016 Life Technologies to Accelerate Adoption of Next-Generation Sequencing in HLA Through Key Partnerships

(Date:5/23/2013)... Jim Fitzpatrick just did it again. ... yet another outside-of-the-box approach to reaching the retail automotive ... daily newscasts to the retail automotive industry, blending the ... broadcast news format. , CBTNews.com is an innovative ... Bridget Everett and Russell Brown host the show with ...

(Date:5/23/2013)... (PRWEB) May 23, 2013 NDI ... funds and develops innovative neurodevice technologies, has launched ... (DBI). DBI will commercialize its groundbreaking technology ... (DBS) therapy for patients with Parkinson’s disease. ... Parkinson’s disease and generates more than $275 million ...

(Date:5/23/2013)... The Viewpoints with Terry Bradshaw show ... a dim life after work ends. A Pew Charitable Trust ... 1955 -- carry more debt, have higher mortgages and are ... Golden Years is not lost. The program brings information to ... after reaching the retirement age of 67, while still enjoying ...

(Date:5/23/2013)... scientifically known about the human potential to cultivate compassion ... are suffering in a way that motivates altruistic behavior. ... Center for Investigating Healthy Minds at the Waisman Center ... be trained to be more compassionate. The report, recently ... is the first to investigate whether training adults in ...

(Date:5/23/2013)... an important human pathogen that can cause rapidly progressing, ... Jennings said., "Until now we have not known how ... a long-standing mystery how it attaches to the airway ... and not get any symptoms, while some people progress ... to know the detail of how the bacterium colonises ...

Breaking Medicine News(10 mins):Health News:Fitzpatrick Advertising Founder Brings Auto Industry into Focus with CBT News 2 Health News:NDI Launches Deep Brain Innovations, LLC 2 Health News:NDI Launches Deep Brain Innovations, LLC 3 Health News:Viewpoints with Terry Bradshaw Presents a Series on Redefining Retirement 2 Health News:Study shows people can be trained to be more compassionate 2 Health News:Study shows people can be trained to be more compassionate 3 Health News:Study shows people can be trained to be more compassionate 4 Health News:New discovery in fight against deadly meningococcal disease 2

[0] Fitzpatrick Advertising Founder Brings Auto Industry into Focus with CBT News [0] NDI Launches Deep Brain Innovations, LLC [0] Viewpoints with Terry Bradshaw Presents a Series on Redefining Retirement [0] Study shows people can be trained to be more compassionate [0] New discovery in fight against deadly meningococcal disease

... Pressure BioSciences, Inc. (Nasdaq: PBIO ) ("PBI" ... corporate activities, including (1) the receipt of a Phase ... National Institutes of Health ("NIH"), (2) a presentation by ... Public Health on the significant advantages in throughput ...

... Positive Committee Recommendation in European UnionCorporate Highlights:- ... Qutenza(TM) (formerly NGX-4010) for treatment of peripheral ... or in combination with other medicinal products ... by U.S. FDA for PHNUpcoming 2009 Milestones:- ...

... to Spot Punctures SoonerNORCROSS, Ga., March 20 Molnlycke ... and the only major surgical glove company with an ... its line this month that helps clinicians notice punctures ... two polyisoprene surgical gloves already in the line. ...

... 20 JLL Partners, a leading private equity investment ... provider of clinical development services (Nasdaq: PDGI ... tender offer by JLL PharmaNet Holdings, LLC ("Parent"), through ... of the outstanding shares of common stock of PharmaNet. ...

... an across-the-board increase in Californai Medicare supplement insurance plan premiums ... for new ways to maximize healthcare dollars and minimize expenses. ... ... March 20, 2009 -- Anthem Blue Cross implemented an across-the-board ...

... indicates that some aspects of peoples, cognitive skills such ... and detect relationships peak at about the age of ... 27. , "This research suggests that some aspects of age-related ... in their 20s and 30s," said Timothy Salthouse, a University ...

Pressure BioSciences, Inc. Provides Corporate Update NeurogesX Reports Fourth Quarter and Year-End 2008 Results Biogel Introduces Polyisoprene (PI) Indicator Underglove JLL Partners Announces Acceptance for Payment of Shares Tendered in PharmaNet Tender Offer and Commencement of Subsequent Offering Period Seniors Seek to Reduce Healthcare Costs as Anthem Blue Cross Increases Premiums Cognitive decline begins in late 20s, study suggests

Straight 8 mm downcutting Royce blade. Can be placed in closed handle for protection. Rigid handle when folded and locked. Straight 8 mm downcutting blades. Handle length folded 109 mm, 4.3 inches....

Duckbill. 3.5 mm tip. Light curve....

2 mm. Angled 13 degrees, 15 mm from angle to tip. Round handle....

2 mm curved tip. Round handle. Designated most popular model or size....

Medicine Products:

Storz Folding Handle Ear Knife Shambaugh & Derlacki Elevator Guilford-Wright Drum Elevator Austin Duckbill Knife-Elevator